Jeannie T. Lee
Directeur/Membre du Conseil chez GSK PLC
Profil
Jeannie T.
Lee is the founder of Translate Bio, Inc. (founded in 2011) and Fulcrum Therapeutics, Inc. (founded in 2015).
She is currently the Director at The Genetics Society of America and a Non-Executive Director at GSK Plc (starting in 2024).
Dr. Lee has an undergraduate degree from Harvard University and a doctorate from Perelman School of Medicine.
Postes actifs de Jeannie T. Lee
| Sociétés | Poste | Début |
|---|---|---|
| GSK PLC | Directeur/Membre du Conseil | 04/03/2024 |
| The Genetics Society of America | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeannie T. Lee
| Sociétés | Poste | Fin |
|---|---|---|
| TRANSLATE BIO, INC. | Fondateur | - |
| FULCRUM THERAPEUTICS, INC. | Fondateur | - |
Formation de Jeannie T. Lee
| Harvard University | Undergraduate Degree |
| Perelman School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| FULCRUM THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
| The Genetics Society of America | |
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
